Segall Bryant & Hamill’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-120,635
| Closed | -$5.79M | – | 437 |
|
2024
Q1 | $5.79M | Sell |
120,635
-1,724
| -1% | -$82.7K | 0.11% | 247 |
|
2023
Q4 | $7.94M | Buy |
122,359
+403
| +0.3% | +$26.2K | 0.15% | 219 |
|
2023
Q3 | $7.98M | Sell |
121,956
-777
| -0.6% | -$50.8K | 0.09% | 249 |
|
2023
Q2 | $7.14M | Buy |
122,733
+567
| +0.5% | +$33K | 0.07% | 290 |
|
2023
Q1 | $7.54M | Buy |
122,166
+1,523
| +1% | +$94K | 0.08% | 271 |
|
2022
Q4 | $7.67M | Buy |
120,643
+8,368
| +7% | +$532K | 0.09% | 258 |
|
2022
Q3 | $8.16M | Buy |
112,275
+2,236
| +2% | +$162K | 0.1% | 244 |
|
2022
Q2 | $7.48M | Buy |
110,039
+32,739
| +42% | +$2.23M | 0.08% | 242 |
|
2022
Q1 | $7.01M | Buy |
77,300
+179
| +0.2% | +$16.2K | 0.07% | 260 |
|
2021
Q4 | $7.04M | Buy |
77,121
+37,611
| +95% | +$3.43M | 0.07% | 259 |
|
2021
Q3 | $3.2M | Buy |
39,510
+1,068
| +3% | +$86.6K | 0.03% | 411 |
|
2021
Q2 | $3.59M | Buy |
+38,442
| New | +$3.59M | 0.03% | 387 |
|